ArticleCase reports in anesthesiology2026
Severe Suspected Anaphylaxis due to Sugammadex in a Healthy Patient Undergoing Endoscopic Sinus Surgery: A Case Report.
Article in Case reports in anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Severe Suspected Anaphylaxis due to Sugammadex in a Healthy Patient Undergoing Endoscopic Sinus Surgery: A Case Report.Case reports in anesthesiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sugammadex is widely used for reversal of steroidal neuromuscular blockade and is generally considered safe; however, rare cases of anaphylaxis have been reported. Case Presentation: A 36-year-old healthy Vietnamese male patient underwent elective endoscopic sinus surgery under general anesthesia. Neuromuscular blockade induced by rocuronium was reversed with sugammadex (4 mg/kg). Within 5-6 min after administration, shortly after arrival in the postanesthesia care unit, the patient developed acute dyspnea, generalized erythema and urticaria, severe hypotension, tachycardia, and bronchospasm, consistent with anaphylactic shock. Immediate treatment with epinephrine, fluid resuscitation, and airway support led to rapid stabilization. The patient recovered fully and was discharged on postoperative Day 3. Conclusions: Sugammadex-induced anaphylaxis, although rare, can be life-threatening even in individuals without prior allergy history. Vigilant monitoring, early recognition, and immediate epinephrine administration are essential to improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.